Clinic
Santa Teresa Family Medical Center
Santa Teresa Family Medical Center was paid $2.02M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 73% of everything it billed.
33Billing provider infoSANTA TERESA FAMILY MEDICAL CENTER
SANTA TERESA, NM 88008
SANTA TERESA, NM 88008
33aNPI1144757063assigned 05/23/2017
33bProvider typeClinic/Center
28Total paid$2.02M
24GClaims42,378
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in New Mexico
Rank by total paid#15 of 52
Median peer was paid$827K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,005 | $173K | |
| 2019 | 8,513 | $253K | |
| 2020 | 7,951 | $281K | |
| 2021 | 5,968 | $274K | |
| 2022 | 6,208 | $315K | |
| 2023 | 5,255 | $357K | |
| 2024incomplete | 4,478 | $364K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 73% | 16,756 | 14,422 | $1.47M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.9% | 2,150 | 1,930 | $139K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 2,565 | 2,273 | $51K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.3% | 362 | 355 | $46K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 505 | 467 | $43K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 6,036 | 5,964 | $30K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 270 | 265 | $24K |
| 99442 | 1.0% | 211 | 200 | $21K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 88 | 13 | $18K |
| 95923 | <1% | 329 | 303 | $16K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 148 | 148 | $16K |
| 80061 | Lipid panel | <1% | 1,200 | 1,189 | $15K |
42 more codes
| 99443 | <1% | 116 | $13K | |
| 93922 | <1% | 317 | $13K | |
| 95921 | <1% | 392 | $12K | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 1,046 | $11K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,073 | $10K |
| 87428 | <1% | 153 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 473 | $10K |
| 96130 | <1% | 54 | $8K | |
| 90686 | <1% | 389 | $7K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 36 | $4K |
| 82947 | <1% | 983 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 415 | $3K |
| 93923 | <1% | 32 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,296 | $2K |
| 93000 | <1% | 184 | $2K | |
| 81002 | <1% | 738 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 111 | $2K |
| 96138 | <1% | 54 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 198 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 36 | $1K |
| 93970 | <1% | 12 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 196 | $914.17 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 436 | $709.72 |
| 90658 | <1% | 47 | $485.86 | |
| 96127 | <1% | 14 | $384.44 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 73 | $357.85 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $170.94 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 14 | $152.86 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 14 | $87.79 |
| G0008 | Administration of influenza virus vaccine | <1% | 12 | $33.56 |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | <1% | 13 | $18.24 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 99 | $2.93 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 64 | $1.76 |
| 99606 | <1% | 237 | $0.12 | |
| 1160F | 0% | 196 | $0.00 | |
| 3077F | 0% | 62 | $0.00 | |
| 3078F | 0% | 1,092 | $0.00 | |
| 1159F | 0% | 103 | $0.00 | |
| 3074F | 0% | 907 | $0.00 | |
| 1170F | 0% | 14 | $0.00 | |
| 1125F | 0% | 27 | $0.00 | |
| 3075F | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVELA, MARIO (OWNER)